Mast cells, neovascularization, and microhemorrhages are associated with saccular intracranial artery aneurysm wall remodeling

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 9, 2014, Pages 855-864

  Ollikainen, Eliisa ^a,b,c   Tulamo, Riikka ^b   Frösen, Juhana ^b,e   Lehti, Satu ^c   Honkanen, Petri ^b   Hernesniemi, Juha ^b,c   Niemelä, Mika ^b,c   Kovanen, Petri T ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Neurosurgery Research Group Biomedicum Helsinki 1   (Finland)

^c WIHURI RESEARCH INSTITUTE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Inflammation; Intracranial aneurysm; Lipid; Mast cell; Microhemorrhage; Neovascularization

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD163 ANTIGEN; CD34 ANTIGEN; CHLORDANE; CHOLESTEROL ESTER; CHYMASE; IRON; TRIACYLGLYCEROL; TRYPTASE; CYTOKINE;

ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN HEMORRHAGE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRON DEPOSITION; IRON METABOLISM; LIPID STORAGE; LYMPHOCYTE; MACROPHAGE; MALE; MAST CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; SACCULAR INTRACRANIAL ARTERY ANEURYSM; T LYMPHOCYTE; UNRUPTURED INTRACRANIAL ANEURYSM; BRAIN ARTERY; CEREBRAL HEMORRHAGE; COMPLICATION; HEART ATRIUM REMODELING; INTRACRANIAL ANEURYSM; LIPID METABOLISM; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANEURYSM, RUPTURED; ATRIAL REMODELING; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; CYTOKINES; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; IRON; LIPID METABOLISM; MALE; MAST CELLS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; YOUNG ADULT;

EID: 84906934246     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000105     Document Type: Article

References (49)

1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007;369:306-18 (Pubitemid 46136491)
2. Vlak MH, Algra A, Brandenburg R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol 2011;10:626-36
3. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysmsVrisk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725-33
4. Kataoka K, Taneda M, Asai T, et al. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 1999;30: 1396-401 (Pubitemid 29296067)
5. Frösen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: Histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004;35:2287-93
6. Frösen J, Tulamo R, Paetau A, et al. Saccular intracranial aneurysm: Pathology and mechanisms. Acta Neuropathol 2012;123:773-86
7. Tulamo R, Frosen J, Junnikkala S, et al. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery 2006;59:1069-76 (Pubitemid 44852101)
8. Tulamo R, Frösen J, Junnikkala S, et al. Complement system becomes activated by the classical pathway in intracranial aneurysm walls. Lab Invest 2010;90:168-79
9. Tulamo R, Frösen J, Paetau A, et al. Lack of complement inhibitors in the outer intracranial artery aneurysm wall associates with complement terminal pathway activation. Am J Pathol 2010;177:3224-32
10. Frösen J, Tulamo R, Heikura T, et al. Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall. Acta Neuropathol Commun 2013;1:71
11. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045-51
12. Oksjoki R, Kovanen PT, Pentikäinen MO. Role of complement activation in atherosclerosis. Curr Opin Lipidol 2003;14:477-82 (Pubitemid 37297302)
13. Kovanen PT. Mast cells: Multipotent local effector cells in atherothrombosis. Immunol Rev 2007;217:105-22 (Pubitemid 46718148)
14. Bot I, van Berkel TJ, Biessen EA. Mast cells: Pivotal players in cardiovascular diseases. Curr Cardiol Rev 2008;4:170-78
15. Rao KN, Brown MA. Mast cells: Multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci 2008;1143:83-104
16. Maaninka K, Lappalainen J, Kovanen PT. Human mast cells arise from a common circulating progenitor. J Allergy Clin Immunol 2013;132: 463-69
17. Mäyränpää MI, Trosien JA, Fontaine V, et al. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J Vasc Surg 2009;50:388-95
18. Swedenborg J, Mäyränpää MI, Kovanen PT. Mast cells: Important players in the orchestrated pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2011;31:734-40
19. Faleiro LC, Machado CR, Gripp A Jr, et al. Cerebral vasospasm: Presence of mast cells in human cerebral arteries after aneurysm rupture. J Neurosurg 1981;54:733-75
20. Hasan D, Chalouhi N, Jabbour P, et al. Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: Preliminary results. J Neuroinflamm 2012;9:222
21. Ishibashi R, Aoki T, Nishimura M, et al. Contribution of mast cells to cerebral aneurysm formation. Curr Neurovasc Res 2010;7:113-24
22. Kaartinen M, Penttilä A, Kovanen PT. Mast cells accompany microvessels in human coronary atheromas: Implications for intimal neovascularization and hemorrhage. Atherosclerosis 1996;123:123-31
23. Willems S, Vink A, Bot I, et al. Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur Heart J 2013;34:3699-706
24. Jeziorska M, Woolley DE. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol 1999;188:189-96 (Pubitemid 29253939)
25. Freeman AF, Crawford SE, Cornwall ML, et al. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 2005;26:578-84 (Pubitemid 43015790)
26. Syväranta S, Helske S, Laine M, et al. Vascular endothelial growth factorYsecreting mast cells and myofibroblasts: A novel self-perpetuating angiogenic pathway in aortic valve stenosis. Arterioscler Thromb Vasc Biol 2010;30:1220-27
27. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-61 (Pubitemid 41416300)
28. Ribatti D, Levi-Schaffer F, Kovanen PT. Inflammatory angiogenesis in atherogenesisVa double-edged sword. Ann Med 2008;40:606-21
29. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-25 (Pubitemid 37509739)
30. Lappalainen H, Laine P, Pentikainen MO, et al. Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol 2004;24:1880-85 (Pubitemid 39350307)
31. Hoh BL, Hosaka K, Downes DP, et al. Stromal cellYderived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls. J Neurosurg 2014;120:73-86
32. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007;27:2514-23 (Pubitemid 350158900)
33. Nielsen JS, McNagny KM. Novel functions of the CD34 family. J Cell Sci 2008;121:3683-92
34. Laine P, Kaartinen M, Penttilä A, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999;99:361-69
35. Kawabori S, Denburg JA, Schwartz LB, et al. Histochemical and immunohistochemical characteristics of mast cells in nasal polyps. Am J Respir Cell Mol Biol 1992;6:37-43
36. Moreno PR, Purushothaman M, Purushothaman KR. Plaque neovascularization: Defense mechanisms, betrayal, or a war in progress. Ann N Y Acad Sci 2012;1254:7Y17
37. Skirgaudas M, Awad IA, Kim J, et al. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery 1996;39:537-45
38. Frösen J, Piippo A, Paetau A, et al. Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: Implications for biological therapy preventing rupture. Neurosurgery 2006;58:534-41
39. De Spiegelaere W, Casteleyn C, Van den Broeck W, et al. Intussusceptive angiogenesis: A biologically relevant form of angiogenesis. J Vasc Res 2012;49:390-404
40. Sluimer JC, Kolodgie FD, Bijnens AP, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009;53:1517-27
41. Bot I, de Jager SC, Zernecke A, et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein EYdeficient mice. Circulation 2007;115:2516-25 (Pubitemid 46763225)
42. Michel JB, Virmani R, Arbustini E, et al. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011;32:1977-85, 1985a, 1985b, 1985c
43. Levy AP, Purushothaman KR, Levy NS, et al. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: Implications for the response to intraplaque hemorrhage and plaque vulnerability. Circ Res 2007;101:106-10 (Pubitemid 47094629)
44. Onofre G, Kolackova M, Jankovicova K, et al. Scavenger receptor CD163 and its biological functions. Acta Med (Hradec Kralove) 2009;52:57-61
45. Pow DV, Diaz CM. AMD-like lesions in the rat retina: A latent consequence of perinatal hemorrhage. Invest Ophthalmol Vis Sci 2008;49:2790-98
46. Yuan XM. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. Free Radic Res 1999;30:221-31 (Pubitemid 29195127)
47. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: From mice to humans. Immunity 2013;38: 1092-104
48. Baram D, Vaday GG, Salamon P, et al. Human mast cells release metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-alpha. J Immunol 2001;167:4008-16 (Pubitemid 32910846)
49. Lee-Rueckert M, Kovanen PT. Extracellular modifications of HDL in vivo and the emerging concept of proteolytic inactivation of prebeta-HDL. Curr Opin Lipidol 2011;22:394-402